thiazoles has been researched along with sr141716 in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Adolfs, TJ; Borst, AJ; Coolen, HK; de Looff, W; Keizer, HG; Kruse, CG; Lange, JH; McCreary, AC; van Stuivenberg, HH; Veerman, W; Verveer, PC; Wals, HC | 1 |
Cadet, JL; Chen, J; Deng, X; Errico, S; Freed, WJ; Lee, CT | 1 |
Schweitzer, P; Slanina, KA | 1 |
Finn, P | 1 |
Kruse, CG; Lange, JH | 1 |
Chu, KL; Dart, MJ; McGaraughty, S; Meyer, MD; Yao, BB | 1 |
Milligan, G; Pediani, JD; Ward, RJ | 1 |
Cox, BF; Dart, M; Diaz, G; Gintant, GA; Green, J; Limberis, JT; Liu, X; Martin, RL; Meyer, M; Polakowski, J; Preusser, L; Su, Z; Yao, B | 1 |
Gyertyán, I; Kassai, F; Varga, B | 1 |
Beggiato, S; Borelli, AC; Bradberry, CW; Ferraro, L; Ferré, S; Goldberg, SR; Justinova, Z; Mascia, P; Melis, M; Panlilio, LV; Pistis, M; Sagheddu, C; Schindler, CW; Schwarcz, R; Secci, ME; Tanda, G; Tomasini, MC | 1 |
Eiler, WJA; Gleason, SD; Smith, JL; Witkin, JM | 1 |
Bales, KL; Dreyer, BK; Freeman, SM; Lackey, NS; Manoli, DS; Simmons, TC | 1 |
12 other study(ies) available for thiazoles and sr141716
Article | Year |
---|---|
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Topics: Administration, Oral; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Hypotension; Hypothermia; Imidazoles; Mice; Models, Molecular; Molecular Conformation; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 2005 |
Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.
Topics: alpha-Tocopherol; Animals; Benzimidazoles; Benzoxazines; Blotting, Northern; Blotting, Western; Calcium Channel Blockers; Calcium Channels; Capsaicin; Cell Count; Cell Death; Cell Lineage; Dizocilpine Maleate; DNA, Single-Stranded; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Excitatory Amino Acid Agonists; Immunohistochemistry; In Situ Nick-End Labeling; Morpholines; N-Methylaspartate; Naphthalenes; Neurons; Neuroprotective Agents; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Ruthenium; Tetrazolium Salts; Thiazoles; TRPC Cation Channels | 2005 |
Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrophysiology; Excitatory Postsynaptic Potentials; GABA Antagonists; Hippocampus; In Vitro Techniques; Male; Meloxicam; Membrane Potentials; Patch-Clamp Techniques; Piperidines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, GABA-A; Rimonabant; Synaptic Transmission; Thiazines; Thiazoles | 2005 |
American Heart Association--scientific sessions 2005. Potential new drugs for various indications. 13-16 November 2005, Dallas, TX, USA.
Topics: American Heart Association; Animals; Cardiotonic Agents; Heart Diseases; Humans; Piperidines; Potassium Channel Blockers; PPAR delta; Pyrazoles; Rimonabant; Thiazoles | 2006 |
Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.
Topics: Animals; Anti-Obesity Agents; CHO Cells; Cricetinae; Cricetulus; Humans; Imidazoles; Isomerism; Models, Chemical; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Solubility; Structure-Activity Relationship; Thiazoles; Triazoles; Water | 2008 |
A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors.
Topics: Action Potentials; Animals; Camphanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Ganglia, Spinal; Male; Neurons; Peripheral Nervous System Diseases; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord; Thiazoles | 2009 |
Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Topics: Alkyl and Aryl Transferases; Benzoxazoles; Cell Line; Cell Membrane; Cloning, Molecular; Cyclohexanols; Extracellular Signal-Regulated MAP Kinases; Humans; Intracellular Signaling Peptides and Proteins; Ligands; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Phenylurea Compounds; Phosphorylation; Piperidines; Plasmids; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Rimonabant; Thiazoles; Urea | 2011 |
Negative inotropic effect of a CB2 agonist A-955840 in isolated rabbit ventricular myocytes is independent of CB1 and CB2 receptors.
Topics: Animals; Benzamides; Calcium Channels, L-Type; Dogs; Heart Ventricles; Inhibitory Concentration 50; Male; Myocardial Contraction; Myocytes, Cardiac; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rabbits; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sarcomeres; Thiazoles | 2011 |
Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats.
Topics: Animals; Anxiety; Disease Models, Animal; Fear; Feeding Behavior; Male; Memory; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant; Thiazoles | 2012 |
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Animals; Astrocytes; Brain; Cells, Cultured; Dronabinol; Glutamic Acid; Kynurenic Acid; Male; Nucleus Accumbens; Prefrontal Cortex; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reward; Rimonabant; RNA, Messenger; Sulfonamides; Thiazoles; Ventral Tegmental Area | 2019 |
A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificity.
Topics: Amino Acids; Animals; Behavior, Addictive; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cannabinoid Receptor Antagonists; Conditioning, Operant; Drug Discovery; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Extinction, Psychological; Feeding Behavior; Male; Models, Animal; Pyridines; Rats; Rats, Sprague-Dawley; Recurrence; Rimonabant; Self Administration; Substance-Related Disorders; Thiazoles | 2019 |
Cannabinoid receptor Type 1 densities reflect social organization in Microtus.
Topics: Animals; Arvicolinae; Brain Chemistry; Cannabinoid Receptor Antagonists; Female; Ligands; Male; Nerve Net; Organ Specificity; Pair Bond; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sex Characteristics; Sexual Behavior, Animal; Species Specificity; Spleen; Thiazoles | 2021 |